Radius Health

Radius Health ROIC

Delisted

The Return on Invested Capital (ROIC) of Radius Health (RDUS) as of Nov 2, 2026 is -25.67 %. In the previous year, Return on Invested Capital (ROIC) was -2.23 % — a change of 1,052.09% (lower).

ROIC

-25.67 %

YoY

1,052.09%

Last updated:

Return on Invested Capital (ROIC) of Radius Health is 2024 -25.67 % . Return on Invested Capital (ROIC) of Radius Health was 2023 -2.23 % . It decreases by 1,052.09% lower compared to the previous year.

The Radius Health ROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROIC
Date
ROIC
Jan 1, 2017
-65.67 USD
Jan 1, 2018
-131.72 USD
Jan 1, 2019
-211.70 USD
Jan 1, 2020
-0.53 USD
Jan 1, 2021
18.13 USD
Jan 1, 2022
14.04 USD
Jan 1, 2023
-2.23 USD
Jan 1, 2024
-25.67 USD
The Radius Health ROIC history
YEARROICYoY
-25.67 %+1,052.09%
-2.23 %-115.87%
14.04 %-22.57%
18.13 %-3,516.32%
-0.53 %-99.75%
-211.70 %+60.72%
-131.72 %+100.58%
-65.67 %+79.51%
-36.58 %+5.10%
-34.81 %-6,505.89%
0.54 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Radius Health Stock analysis

What does Radius Health do? Radius Health Inc. is an American pharmaceutical company specializing in the research, development, and marketing of products in the areas of osteoporosis, cancer therapy, and endocrinology. The company was founded in 2003 and is headquartered in Waltham, Massachusetts. The history of Radius Health Inc. began with the discovery of a new compound called Abaloparatide, which was intended for use in the treatment of osteoporosis. The company initiated a Phase III clinical trial to evaluate the efficacy and tolerability of the medication. In 2016, Abaloparatide was approved by the U.S. Food and Drug Administration (FDA) for the treatment of postmenopausal osteoporosis. Since then, Radius Health Inc. has evolved into a leading company specializing in improving women's health. The company has expanded its activities to include oncology and endocrinology and relies on innovative technologies and research to provide better treatment options and medications for patients. The business model of Radius Health Inc. is based on the development and marketing of cost-effective and effective products for the treatment of diseases. The company conducts extensive clinical research and strives to develop new drugs and therapies to improve the lives of women. Radius Health Inc. employs an open and agile corporate culture that promotes innovation and prioritizes the needs of patients. The products offered by Radius Health Inc. include a wide range of medications used in the treatment of osteoporosis, breast cancer, and other diseases. Abaloparatide, the company's flagship product, is a recombinant peptide agonist that stimulates bone formation and reduces the risk of fractures in postmenopausal women. Other products include Elacestrant, an investigative drug for the treatment of breast cancer, and RAD1901, a selective estrogen receptor modulator used in the treatment of hormone-dependent cancers. The company is also active in the field of digital health. Radius Health Inc. has developed an augmented reality app that assists doctors and patients in visualizing bone fractures and other conditions. The app is currently being tested in clinical trials and is expected to be widely used in the future. Overall, Radius Health Inc. is known for its innovative research activities and efforts to improve women's health. The company has an experienced and dedicated team of researchers, scientists, and executives working together to create better treatment options for patients. With a strong pipeline of products and a vision for the future of healthcare, Radius Health Inc. is on track to become a leading provider of medical products and services. Radius Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Radius Health stock

Return on Invested Capital (ROIC) of Radius Health is -25.67 % in 2024.

Return on Invested Capital (ROIC) of Radius Health changed from -2.23 % to -25.67 %, representing a 1,052.09% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Invested Capital (ROIC) Radius Health since 2006 – with annual values, charts, and detailed analysis.

ROIC measures how effectively a company uses its invested capital to generate profits. A ROIC above the cost of capital creates shareholder value.

ROIC = NOPAT / Invested Capital

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Invested Capital (ROIC)'s Radius Health with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Invested Capital (ROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Invested Capital (ROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Radius Health

All Key Metrics — Radius Health